Log In
BCIQ
Print this Print this
 

CDX-014 (formerly CR014-vcMMAE)

  Manage Alerts
Collapse Summary General Information
Company Celldex Therapeutics Inc.
DescriptionAntibody-drug conjugate (ADC) composed of a humanized anti-hepatitis A virus cellular receptor 1 (HAVCR1; TIM1) mAb and monomethyl auristatin E (MMAE)
Molecular Target Hepatitis A virus cellular receptor 1 (HAVCR1) (TIM1)
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today